Advancing novel medicines to empower the everyday lives of people living with hereditary angioedema (HAE).
Cambridge, MA
Joined June 2011
- Tweets330
- Following64
- Followers609
- Likes25
The #HAE community is gathering in Ottawa, and KalVista is here! Meet us at the 2026 HAEi Regional Conference Americas, October 23–25, hosted by @HAEDAY. Learn more about the conference: bit.ly/4z2hW1d
Long-term prophylaxis can help people manage #HAE—but it often does not eliminate attacks. Real-world data reinforce that on-demand treatment remains foundational to care, helping people stay prepared to treat whenever an attack occurs: bit.ly/4z7WDLz
KalVista is proud to be a 2026 @FiercePharma Fierce 50 Breakthrough Honoree—a recognition we share with the entire HAE community: bit.ly/4h8PrZo
Interim results from the KONFIDENT-S OLE have been published in JACI Global. The analysis evaluated the safety and efficacy of our oral on-demand treatment in people with #HAE receiving long-term prophylaxis: bit.ly/4xzD6CA
We’re onsite in Berlin for the 8th #BradykininSymposium. Come find us to talk kallikrein-kinin science and the latest progress in #HAE.
ALT Bradykinin Symposium 2026
KalVista is now part of @ChiesiGRD. Our commitment to the #HAE community hasn't changed—and this channel is still your source for updates.
Follow along here and @ChiesiGroup for what comes next.
Today, KalVista officially joins @ChiesiGroup. With @ChiesiGRD’s global reach and shared commitment to people living with rare diseases, our mission to transform the treatment landscape for people living with #HAE only grows from here. bit.ly/43wdTMF
Highlights from ISPOR and #EAC2026: new data on the burden injectable on-demand treatment can place on young children living with #hereditaryangioedema and their caregivers. Learn more: bit.ly/3RrQSrx
KalVista has entered into a definitive agreement to be acquired by @ChiesiGroup. Together with the HAE community, we delivered the first oral on-demand treatment, changing what’s possible for patients. With Chiesi, we are confident that we can go even further. Learn more about the transaction: bit.ly/42AbrUL
Important disclosure information: bit.ly/4t2e7Fm
#TeamKalVista is proud to support @HAEDAY LEAP, an education program designed to empower the next generation of #HAE advocates. We were on-site in Copenhagen for the Kick-Off Meeting and were inspired by the passion of the Class of 2026. Learn more about LEAP: bit.ly/4eOJqjE
New publication from the KONFIDENT trial in @ClinExpAllergy: Participants experienced significantly reduced anxiety associated with #HAE attacks after treatment with our oral on-demand therapy vs placebo—addressing an often underrecognized burden of the disease. Read more: bit.ly/4cojppO
Patient experience matters. At #AMCP2026, #TeamKalVista will present data exploring how anxiety may impact healthcare utilization in #HAEpatients on long-term prophylaxis. Stop by poster #219 and join the conversation.
Today, we announced positive interim data from our Phase 3 KONFIDENT-KID trial evaluating the first and only oral on-demand treatment for HAE in children ages 2-11. Learn more about the results shared at the @HAE International (HAEi) 2026 Global Angioedema Leadership Conference: bit.ly/4s4Iz1c
#TeamKalVista is sharing new clinical data and patient survey research at the @HAEDAY 2026 Global Angioedema Leadership Conference. Learn more about our presentations: bit.ly/41sVBL6
2025 proved to be a pivotal year for both #TeamKalVista and the #HAE community. Learn about our 2025 revenue results and how we're building on this momentum in 2026: bit.ly/4lNdaPj
On March 25 at 8:30 am ET, we’re hosting a live conference call and webcast to discuss our 2025 financial results and provide a corporate update. Learn more: bit.ly/4uwCtJr
Our very own Nicole Sweeny is an @MMMnews Women of Distinction honoree! Nicole leads #TeamKalVista as a champion for the #HAEcommunity and a mentor and visionary within our own walls. Join us in celebrating this well-deserved honor! #MMMWomenofDistinction
See what’s next for #TeamKalVista. CEO Ben Palleiko will be sharing our #HAE progress and hosting fireside chats at the @TDBank_US and the Citizens Life Sciences conferences this month. Learn more: bit.ly/4bjkGhh
